Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swetha Srinivasan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2020
Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative StudySwetha Srinivasan, Heather Hampel, Jennifer Leeman, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 22, 2009
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinomaDavid A Kooby, Vasili Egnatashvili, Swetha Srinivasan, et al.
The Journal of Investigative Dermatology|May 7, 2026
MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic DermatitisJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Frontiers in Genetics|July 21, 2022
Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic ReviewEmily C Shen, Swetha Srinivasan, Lauren E Passero, et al.
ACR Open Rheumatology|October 4, 2024
Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human DiseaseRachel E Twomey, Stuart J Perper, Susan V Westmoreland, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M Kirkwood, Peter Mohr, Christoph Hoeller, et al.
Inflammatory Bowel Diseases|June 18, 2015
miRNA-26b Overexpression in Ulcerative Colitis-associated CarcinogenesisNatalya Benderska, Anna-Lena Dittrich, Sabine Knaup, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2024
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world dataJustin C Moser, Shailender Bhatia, Asim Amin, et al.
Clinical Lung Cancer|April 13, 2023
Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung CancerOyomoare L Osazuwa-Peters, Lauren E Wilson, Devon K Check, et al.
Blood|September 14, 2010
GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppressionWeston P Miller, Swetha Srinivasan, Angela Panoskaltsis-Mortari, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2020
Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative StudySwetha Srinivasan, Heather Hampel, Jennifer Leeman, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 22, 2009
Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinomaDavid A Kooby, Vasili Egnatashvili, Swetha Srinivasan, et al.
The Journal of Investigative Dermatology|May 7, 2026
MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic DermatitisJoshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Frontiers in Genetics|July 21, 2022
Barriers and Facilitators for Population Genetic Screening in Healthy Populations: A Systematic ReviewEmily C Shen, Swetha Srinivasan, Lauren E Passero, et al.
ACR Open Rheumatology|October 4, 2024
Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human DiseaseRachel E Twomey, Stuart J Perper, Susan V Westmoreland, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2025
Patient-reported outcomes with adjuvant nivolumab versus placebo after complete resection of stage IIB/C melanoma in the randomized phase 3 CheckMate 76 K trialJohn M Kirkwood, Peter Mohr, Christoph Hoeller, et al.
Inflammatory Bowel Diseases|June 18, 2015
miRNA-26b Overexpression in Ulcerative Colitis-associated CarcinogenesisNatalya Benderska, Anna-Lena Dittrich, Sabine Knaup, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2024
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world dataJustin C Moser, Shailender Bhatia, Asim Amin, et al.
Clinical Lung Cancer|April 13, 2023
Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung CancerOyomoare L Osazuwa-Peters, Lauren E Wilson, Devon K Check, et al.
Blood|September 14, 2010
GVHD after haploidentical transplantation: a novel, MHC-defined rhesus macaque model identifies CD28- CD8+ T cells as a reservoir of breakthrough T-cell proliferation during costimulation blockade and sirolimus-based immunosuppressionWeston P Miller, Swetha Srinivasan, Angela Panoskaltsis-Mortari, et al.
Pageof 3